Categories

Sign Up to Receive the Latest Trading Tips and News from Prosper



    February 5, 2019

    Evolus, Part II

    Evolus, Inc. (EOLS) is up again today following FDA approval of its first product, Jeuveau, on Friday. The stock was up over 25% at the time this content was recorded. Part of this rally is likely due to the fact that the stock had a large percentage of short positions. In fact, nearly a fifth […]

    Read Article
    February 4, 2019

    Did Evolus Just Find the Fountain Of Youth?

    Evolus Inc (EOLS) shares are up sharply today after the company gained FDA approval for their flagship product, Jeuveau, a cosmetic injection used to reduce the appearance of wrinkles on the face. This means Jeuveau is a direct competitor to Botox, which of course is a big seller for its parent company, Allergan. Here’s a […]

    Read Article